PharmaShots Weekly Snapshots (December 27 - 30, 2022)
Vericel and MediWound Receive the US FDA’s Approval of NexoBrid for Severe Thermal Burns
Published: Dec 30, 2022 | Tags: Vericel, MediWound, NexoBrid, Severe Thermal Burns, Regulatory, US, FDA, Approval
Published: Dec 30, 2022 | Tags: Mayflower Bioventures, Primera Therapeutics, Cellectis, Mitochondrial Diseases, Gene Editing Platform, Biotech
Published: Dec 30, 2022 | Tags: Opus Genetics, IC-100, IC-200, BEST1, RHO-adRP, Inherited Retinal Diseases, Pharma
Published: Dec 30, 2022 | Tags: PDS Biotech, PDS0101, M9241, bintrafusp alfa,anal, cervical, head and neck, vaginal, vulvar cancers, Clinical Trial, P-II
Published: Dec 30, 2022 | Tags: SeaStar Medical, Nuwellis, Selective Cytopheretic Device, Acute Kidney Injury, MedTech
Pfizer Reports P-III Study (BENEGENE-2) Results of Fidanacogene Elaparvovec for Hemophilia B
Published: Dec 30, 2022 | Tags: Pfizer, Fidanacogene Elaparvovec, Hemophilia B, Clinical Trial, P-III, BENEGENE-2
Published: Dec 29, 2022 | Tags: AstraZeneca, Imfinzi, durvalumab, Imjudo, tremelimumab, Liver, Non-Small Cell Lung Cancers, Regulatory, MHLW, Approval
Junshi Biosciences Reports P-III Clinical Trial Results of VV116 for Severe COVID-19
Published: Dec 29, 2022 | Tags: Junshi Biosciences, VV116, COVID-19, Clinical Trial, P-III, Clinical Trial
Published: Dec 29, 2022 | Tags: TG Therapeutics, Briumvi, ublituximab-xiiy, Multiple Sclerosis, Regulatory, US, FDA, Approval
Mitsui to Acquire Sumitomo Pharma Animal Health
Published: Dec 29, 2022 | Tags: Mitsui, Sumitomo Pharma Animal Health, Marupi Lifetech, M&A, Japan, Animal Health
Pfizer’s BLA for MenABCWY is Accepted by the US FDA as Preventive Measure for Meningococcal Disease
Published: Dec 29, 2022 | Tags: Pfizer, MenABCWY, Meningococcal Disease, Regulatory, US, Europe, US FDA, FDA, BLA
Acasti Reports Results of GTX-102 in P-I Bridging Study for the Treatment of Ataxia Telangiectasia
Published: Dec 29, 2022 | Tags: Acasti, GTX-102, Ataxia Telangiectasia, Clinical Trial, P-I, Bridging Study, Crossover Study, US FDA
Published: Dec 28, 2022 | Tags: AstraZeneca, Calquence, acalabrutinib, Chronic Lymphocytic Leukaemia, Regulatory, MHLW, Approval
Published: Dec 28, 2022 | Tags: Kala Pharmaceuticals, KPI-012, Persistent Corneal Epithelial Defect, Regulatory, US, FDA, IND
Published: Dec 28, 2022 | Tags: SpringWorks, Nirogacestat, Desmoid Tumors, Regulatory, NDA, US, FDA
EOFlow Seeks Approval of Wearable Disposable Insulin Pump for Diabetes in the US
Published: Dec 28, 2022 | Tags: EOFlow, Wearable Disposable Insulin Pump, EOPatch, Diabetes, Regulatory, Medtech, US
Published: Dec 28, 2022 | Tags: Eli Lilly, PeptiDream, Novel Peptide Drug Conjugates, Peptide Discovery Platform System, Biotech
Henlius Entered into an Exclusive License Agreement with Fosun Pharma for HANSIZHUANG in the US
Published: Dec 28, 2022 | Tags: Henlius, Fosun Pharma, HANSIZHUANG, MSI-H solid tumours, extensive-stage small cell lung cancer, small cell lung cancer, US, Pharma
Nanobiotix Initiates US Patient Enrollment of P-III Trial (NANORAY-312) for Head and Neck Cancer
Published: Dec 27, 2022 | Tags: Nanobiotix, NBTXR3, Head, Neck Cancer, Clinical Trial, P-III, NANORAY-312 trial
Published: Dec 27, 2022 | Tags: Orthofix, Trinity Elite Cellular Bone Allograft, Lumbar Fusion Procedures, MedTech
Published: Dec 27, 2022 | Tags: Junshi, Hikma, Toripalimab, Cancer, Pharma, Middle East, North Africa
Published: Dec 27, 2022 | Tags: Antengene, MSD, ATG-037, Keytruda, pembrolizumab, Solid Tumors, Pharma
Jiangsu Recbio Technology Reports P-II Study Results of Two-Component COVID-19 Vaccine ReCOV
Published: Dec 27, 2022 | Tags: Jiangsu Recbio Technology, COVID-19 Vaccine, Omicron BF.7, BA.2.75, ReCOV, Clinical Trial
Published: Dec 27, 2022 | Tags: Regeneron, Libtayo, cemiplimab, Cervical Cancer, Regulatory, MHLW, Approval
Related Post: PharmaShots Weekly Snapshots (December 19 - 23, 2022)
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.